Form 4 for WST West Pharmaceutical Services
Accepted 2026-09-15 16:37:47 ET · period of report 2026-09-11 · accession 0000105770-26-000110 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-15 16:37 | 2026-09-11+ | WST | Favorite Annette F | SVP, Chief HR Off | M - OptEx | $89.64 | +7,524 | 24.3K | +45% | +$674.5K |
| DMT | 2026-09-15 16:37 | 2026-09-11+ | WST | Favorite Annette F | SVP, Chief HR Off | S - Sale+OE | $355.03 | -7,524 | 21.8K | -26% | -$2.67M |
| DMT | 2026-09-15 16:37 | 2026-09-11+ | WST | Favorite Annette F | SVP, Chief HR Off | M - OptEx | $0.00 | -7,524 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-11 | M | A | 2,500 | $89.64 | 24,317.81 | D | — | — | |
| 2 | Common | Common Stock | 2026-09-11 | S | D | 2,500 | $345.00 | 21,817.81 | D | — | — | |
| 3 | Common | Common Stock | 2026-09-14 | M | A | 2,500 | $89.64 | 24,317.81 | D | — | — | |
| 4 | Common | Common Stock | 2026-09-14 | S | D | 2,500 | $355.00 | 21,817.81 | D | — | — | |
| 5 | Common | Common Stock | 2026-09-15 | M | A | 2,524 | $89.64 | 24,341.81 | D | — | — | |
| 6 | Common | Common Stock | 2026-09-15 | S | D | 2,524 | $365.00 | 21,817.81 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-09-11 | M | D | 2,500 | $0.00 | 5,024 | D | $89.64 · — to 2028-02-20 | 2,500 Common Stock | (F1) This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-09-14 | M | D | 2,500 | $0.00 | 2,524 | D | $89.64 · — to 2028-02-20 | 2,500 Common Stock | (F1) This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-09-15 | M | D | 2,524 | $0.00 | 0 | D | $89.64 · — to 2028-02-20 | 2,524 Common Stock | (F1) This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019. |